-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

331. Pathophysiology of Thrombosis: Poster II

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, anticoagulant drugs, Coronaviruses, multiple myeloma, SARS-CoV-2/COVID-19, Bleeding and Clotting, Diseases, Non-Biological, Hodgkin Lymphoma, Therapies, Non-Hodgkin Lymphoma, Pregnancy, Thrombosis, Plasma Cell Disorders, Lymphoid Malignancies, Study Population, Thromboembolism, Clinically relevant, Thrombotic Disorders, VTE
Sunday, December 6, 2020: 7:00 AM-3:30 PM

Eric S. Mullins, MD1,2, Rebecca Geer1*, Megan Metcalf1*, Jeanne Piccola1*, Adam Lane, PhD2,3*, Lee Ann E Conard, RPh, DO, MPH2,4* and Tanya Lilliane Kowalczyk Mullins, MD, MS2,4*

1Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
2University of Cincinnati - College of Medicine, Cincinnati, OH
3Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
4Division of Adolescent and Transition Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Patrick Van Dreden, PhD1, Guillaume Voiriot2*, Alexandre Alabbadi3*, Ismail Elalamy, MD, PhD4,5, Loula Papageorgiou5,6*, Hélène Cost7*, Aurélie Rousseau, Ph.D8,9*, Matthieu Turpin3*, Muriel Fartoukh3* and Grigorios T. Gerotziafas10,11,12,13*

1Clinical Research, Stago, Gennevilliers, France
2Service de réanimation et USC médico-chirurgicale, AP-HP, Hôpital Tenon, Paris, FRA
3Service de réanimation et USC médico-chirurgicale, Hôpital Tenon, Hôpitaux Universitaires de l’Est Parisien, Assistance Publique Hôpitaux de Paris, Paris, France
4Department of Haematology, Tenon University Hospital, Assistance Publique Hopitaux de Paris, Paris, FRA
5Cancer Biology and Therapeutics, INSERM U938, Institut Universitaire de Cancérologie (IUC), Université Pierre et Marie Curie (UPMC), Sorbonne Universities, Paris. Faculté de Médecine Pierre et Marie Curie, Paris, France
6Department of haematology, Tenon University Hospital Assistance Publique Hopital de Paris, Paris, France
7Clinical research department, Diagnostica Stago, gennevilliers, France
8Clinical Research Department, Diagnostica Stago, Gennevilliers, France
9INSERM U938, Faculté de Médecine Pierre et Marie Curie, Université Paris VI, Paris,France, Paris, France
10Service d'Hématologie Biologique Hôpital Tenon, Paris, France, Paris, France
11Institut Universitaire de Cancérologie, Sorbonne University, Paris, France
12INSERM U938, Faculté de Médecine Pierre et Marie Curie, Université Paris VI,, Paris, France
13Service d'hématologie clinique et de thérapie cellulaire, Saint Antoine Hospital, Paris, France

Rida Abid Hasan, MD1, Laura Coughlin2*, Nicole Poulides3*, Xiaowei Zhan, PhD2*, Ayesha Zia, MD3 and Andrew Y. Koh, MD4*

1Bloodworks Northwest, Seattle, WA
2University of Texas Southwestern Medical Center, Dallas
3University of Texas Southwestern Medical Center, Dallas, TX
4Univ. of Texas Southwestern Medical Ctr., Dallas, TX

Anna L. Parks, MD1, Swetha Kambhampati, MD2, Bita Fakhri, MD, MPH3, Charalambos Andreadis, MD1, Lissa Gray, MSN2*, Sandy W. Wong, MD2, Nina Shah, MD4 and Margaret C. Fang, MD, MPH5*

1University of California, San Francisco, San Francisco, CA
2Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA
3Division of Hematology and Oncology, University of California, San Francisco, CA
4Associate Professor of Medicine, University of California San Francisco, San Francisco, CA
5Division of Hospital Medicine, University of California, San Francisco, San Francisco, CA

Darko Antic1,2,3*, Vladimir Otasevic1,2*, Sven Borchmann4,5*, Horst Muller4,5*, Vojin Vukovic1,2*, Vladislava Djurasinovic1,2*, Kristina Tomic1,2*, Biljana Mihaljevic1,2,3*, Grigoris Gerotziafas, MD, PhD6,7*, Andreas Engert, MD4,5 and Jawed Fareed, PhD8

1Clinic for hematology, Clinical Center Serbia, Belgrade, Serbia
2Serbian Lymphoma Group, Belgrade, Serbia
3Medical Faculty, University of Belgrade, Belgrade, Serbia
4Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne, Germany
5University of Cologne, German Hodgkin Study Group (GHSG), Cologne, Germany
6Sorbonne Universities, Faculty of Medicine, Cancer, Haemostasis and Angiogenesis Research Group, INSERM U938, Institut Universitaire de Cancérologie,, Paris, France
7Service d'hematologie biologique Hôpital Tenon APHP, Thrombosis center, Paris, France
8Pathology, Loyola University Medical Center, Maywood, IL

Elizabeth Behrens, MD1, Surbhi Warrior, MD MPH1*, Joshua Thomas, MD1*, Xavier Pombar, DO2*, Sefer Gezer, MD3,4, Parameswaran Venugopal, MD3,4 and Shivi Jain, MD, MBBS3,4

1Department of Internal Medicine, Rush University Medical Center, Chicago, IL
2Division of Obstetrics and Gynecology, Rush University Medical Center, Chicago, IL
3Rush University Cancer Center, Chicago, IL
4Division of Hematology Oncology, Rush University Medical Center, Chicago, IL

Mo Yang1,2*, Liang Li, PhD2*, Lixia Zhou2*, Hua Zhang3*, Liuming Yang1*, Beng H Chong, MBBS, PhD4,5 and Yanqi Yang3*

1Lianjiang People's Hospital, Lianjiang, China
2The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China
3Department of Cardiovascular Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
4Medicine, University of New South Wales, Kogarah, Australia
5St George Hospital, Sydney, Australia

Danielle Vlazny, PA-C1*, Damon E. Houghton, MD, MS2,3, Ryan Meverden, PA-C1*, Paul Daniels, MD4*, Matthew Bartlett, M.B., B.Ch., B.A.O4*, Gina Hesley, MD5*, Thanila Macedo, MD5*, Alexander Lekah, MD5* and Waldemar E. Wysokinski, MD, PhD6*

1Gonda Vascular Center, Mayo Clinic, Rochester, MN
2Gonda Vascular Center, Thrombophilia Clinic, Department of Cardiovascular Diseases, Mayo Clinic, Rochester
3Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Rochester, MN
4Department of Internal Medicine, Mayo Clinic, Rochester, MN
5Department of Radiology, Mayo Clinic, Rochester, MN
6Gonda Vascular Center, Thrombophilia Clinic, Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN

*signifies non-member of ASH